Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
ASH Updates on Large Cell & Aggressive Lymphomas: Antibody Loncastuximab Tesirine in R/R DLBCL, Glofitamab Step-Up Dosing in Hard-to-Treat R/R NHL, Subcutaneous Epcoritamab in R/R NHL, M-CHOP for DLBCL
Comments 0
Login to view comments.
Click here to Login
